CN103930105B - 2-(n,n-二甲基氨基)-丙酸十二烷基酯的活性对映体 - Google Patents

2-(n,n-二甲基氨基)-丙酸十二烷基酯的活性对映体 Download PDF

Info

Publication number
CN103930105B
CN103930105B CN201180054224.5A CN201180054224A CN103930105B CN 103930105 B CN103930105 B CN 103930105B CN 201180054224 A CN201180054224 A CN 201180054224A CN 103930105 B CN103930105 B CN 103930105B
Authority
CN
China
Prior art keywords
ddaip
dimethylamino
pharmaceutically active
active compound
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180054224.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN103930105A (zh
Inventor
B·B·达玛吉
R·马丁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nexmed Holdings Inc
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Publication of CN103930105A publication Critical patent/CN103930105A/zh
Application granted granted Critical
Publication of CN103930105B publication Critical patent/CN103930105B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201180054224.5A 2010-12-02 2011-11-30 2-(n,n-二甲基氨基)-丙酸十二烷基酯的活性对映体 Expired - Fee Related CN103930105B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41899610P 2010-12-02 2010-12-02
US61/418,996 2010-12-02
PCT/US2011/062579 WO2012075107A2 (en) 2010-12-02 2011-11-30 Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate

Publications (2)

Publication Number Publication Date
CN103930105A CN103930105A (zh) 2014-07-16
CN103930105B true CN103930105B (zh) 2019-11-01

Family

ID=46172526

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180054224.5A Expired - Fee Related CN103930105B (zh) 2010-12-02 2011-11-30 2-(n,n-二甲基氨基)-丙酸十二烷基酯的活性对映体

Country Status (20)

Country Link
US (1) US20130267562A1 (enExample)
EP (1) EP2646015B1 (enExample)
JP (1) JP6109075B2 (enExample)
KR (1) KR102004552B1 (enExample)
CN (1) CN103930105B (enExample)
AU (2) AU2011336692B2 (enExample)
BR (1) BR112013012799A8 (enExample)
CA (1) CA2817417C (enExample)
CL (1) CL2013001391A1 (enExample)
CR (1) CR20130324A (enExample)
ES (1) ES2801999T3 (enExample)
IL (1) IL226173A (enExample)
MX (1) MX2013005522A (enExample)
NZ (1) NZ609826A (enExample)
PH (1) PH12013501104A1 (enExample)
PL (1) PL2646015T3 (enExample)
RU (1) RU2679308C2 (enExample)
SG (2) SG10201803321TA (enExample)
WO (1) WO2012075107A2 (enExample)
ZA (1) ZA201304840B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014028780A2 (en) * 2012-08-15 2014-02-20 Nexmed Holdings, Inc. Antifungal compounds and methods of use
US8900625B2 (en) 2012-12-15 2014-12-02 Nexmed Holdings, Inc. Antimicrobial compounds and methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306502A (zh) * 1999-05-19 2001-08-01 尼克斯梅德控股公司 2－(n,n－二甲基氨基)－丙酸十二酯的结晶盐

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
JP5160018B2 (ja) * 2002-06-25 2013-03-13 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド 非晶質医薬組成物を用いる経皮送達速度調節
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
EP1635770B1 (en) * 2003-03-21 2009-05-27 Nexmed Holdings, Inc. Antifungal nail coat and method of use
WO2005009510A2 (en) * 2003-07-23 2005-02-03 The Regents Of The University Of California Penetration enhancer combinations for transdermal delivery
PL1670433T3 (pl) * 2003-10-10 2013-03-29 Ferring Bv Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
WO2005051960A2 (en) * 2003-11-22 2005-06-09 Midwest Research Laboratories, Llc Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents
RU2012153177A (ru) * 2010-05-04 2014-06-20 Нексмед Холдингс, Инк. Композиции низкомолекулярных терапевтических средств
US8900625B2 (en) * 2012-12-15 2014-12-02 Nexmed Holdings, Inc. Antimicrobial compounds and methods of use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306502A (zh) * 1999-05-19 2001-08-01 尼克斯梅德控股公司 2－(n,n－二甲基氨基)－丙酸十二酯的结晶盐

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Dimethylamino Acid Esters as Biodegradable and Reversible TransdermalPermeation Enhancers: Effects of Linking Chain Length, Chirality and Polyfluorination;Jakub Novotný et al.;《Pharmaceutical Research》;20090430;第26卷(第4期);811-821 *

Also Published As

Publication number Publication date
SG10201803321TA (en) 2018-06-28
ES2801999T3 (es) 2021-01-15
BR112013012799A8 (pt) 2018-01-09
CN103930105A (zh) 2014-07-16
AU2011336692B2 (en) 2017-02-16
KR20140023875A (ko) 2014-02-27
AU2017200314A1 (en) 2017-02-02
MX2013005522A (es) 2013-07-17
CA2817417C (en) 2020-12-29
SG190199A1 (en) 2013-06-28
CL2013001391A1 (es) 2013-11-08
US20130267562A1 (en) 2013-10-10
KR102004552B1 (ko) 2019-10-01
PL2646015T3 (pl) 2020-11-30
EP2646015A2 (en) 2013-10-09
RU2679308C2 (ru) 2019-02-07
CR20130324A (es) 2013-08-13
BR112013012799A2 (pt) 2016-09-13
WO2012075107A2 (en) 2012-06-07
WO2012075107A3 (en) 2014-03-06
RU2013119439A (ru) 2015-01-10
JP6109075B2 (ja) 2017-04-05
IL226173A (en) 2016-10-31
NZ609826A (en) 2016-03-31
JP2014514243A (ja) 2014-06-19
ZA201304840B (en) 2014-04-30
EP2646015A4 (en) 2015-04-08
EP2646015B1 (en) 2020-04-22
AU2011336692A1 (en) 2013-05-30
IL226173A0 (en) 2013-07-31
PH12013501104A1 (en) 2013-07-08
CA2817417A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
JP5466006B2 (ja) 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
RU2128160C1 (ru) Трометаминная соль (+)-(s)-2-(3-бензоилфенил)пропионовой кислоты, способ ее получения, фармацевтическая композиция
JP5542436B2 (ja) 非常に速い皮膚透過率を有するジクロフェナクの正荷電水溶性プロドラッグ
HUE034235T2 (en) Use of cannabidiol prodrugs in topical and transdermal delivery with microdisks
KR100687806B1 (ko) 특정약의 질산에스테르 및 질산염
CN103930105B (zh) 2-(n,n-二甲基氨基)-丙酸十二烷基酯的活性对映体
JP6073202B2 (ja) 静脈におけるウイルスの治療
AU2014201024B2 (en) Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate
HK1198014A (en) Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
HK1190305A (en) Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
HK1190305B (en) Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
JP5855599B2 (ja) 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
JP2009533428A (ja) 筋肉内抗ウイルス処置
US20170348252A1 (en) Preparation and Use of Ketamine Derivatives and Ketamine Modifiers in the Treatment of Pain
JP6165816B2 (ja) 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
AU2006226721A1 (en) Addition salts of tolperisone, processes for their preparation and use thereof
US20240269226A1 (en) Combination therapy with semax and cannabidiol
AU2006347925B2 (en) Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate
HK1198001A (en) Positively charged water-soluble prodrugs of diclofenac with very fast skin penetration rate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1198014

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1198014

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20191101

Termination date: 20211130